ArticleJournal of hepatology2021

Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma.

Chunxiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.